Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Abbie E Fearon

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Nature Structural & Molecular Biology|February 7, 2014
Grb-ing receptor activation by the tailAbbie E Fearon, Richard P Grose
Trends in Cell Biology|December 4, 2014
Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunctionEdward P Carter, Abbie E Fearon, Richard P Grose
The International Journal of Biochemistry & Cell Biology|October 24, 2013
FGFR signalling in women's cancersAbbie E Fearon, Charlotte R Gould, Richard P Grose
Iscience|October 14, 2021
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosisAbbie E Fearon, Coenraad F Slabber, Andrii Kuklin, et al.
International Journal of Molecular Sciences|April 13, 2023
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via <i>PHLDA1</i> InductionNatasha S Clayton, Edward P Carter, Abbie E Fearon, et al.
Cell Reports|March 1, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Cell Reports|June 4, 2026
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Nature Structural & Molecular Biology|February 7, 2014
Grb-ing receptor activation by the tailAbbie E Fearon, Richard P Grose
Trends in Cell Biology|December 4, 2014
Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunctionEdward P Carter, Abbie E Fearon, Richard P Grose
The International Journal of Biochemistry & Cell Biology|October 24, 2013
FGFR signalling in women's cancersAbbie E Fearon, Charlotte R Gould, Richard P Grose
Iscience|October 14, 2021
Fibroblast growth factor receptor 3 in hepatocytes protects from toxin-induced liver injury and fibrosisAbbie E Fearon, Coenraad F Slabber, Andrii Kuklin, et al.
International Journal of Molecular Sciences|April 13, 2023
HDAC Inhibition Restores Response to HER2-Targeted Therapy in Breast Cancer via <i>PHLDA1</i> InductionNatasha S Clayton, Edward P Carter, Abbie E Fearon, et al.
Cell Reports|March 1, 2018
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Cell Reports|June 4, 2026
PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven CancerAbbie E Fearon, Edward P Carter, Natasha S Clayton, et al.
Pageof 1